Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Name: Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy
License: Public Domain

NKGen Biotech, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

adult

refractory cancer, metastatic cancer, recurrent cancer, unresectable carcinoma, solid tumor, adult, advanced cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143573
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.